Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parasitic Diseases

  Free Subscription


Articles published in Parasite Immunol

Retrieve available abstracts of 99 articles:
HTML format



Single Articles


    March 2021
  1. PRADHAN S, Ghosh S, Hussain S, Paul J, et al
    Linking membrane fluidity with defective antigen-presentation in leishmaniasis.
    Parasite Immunol. 2021 Mar 23:e12835. doi: 10.1111/pim.12835.
    PubMed     Abstract available


    January 2021
  2. CARABALLO-GUZMAN A, Ospina-Villa JD, Cuesta-Caicedo A, Sanchez-Jimenez MM, et al
    Immunoproteomics characterization of Leishmania panamensis proteins for potential clinical diagnosis of mucosal leishmaniasis.
    Parasite Immunol. 2021 Jan 23:e12824. doi: 10.1111/pim.12824.
    PubMed     Abstract available


  3. ZOU ZQ, Liu M, Zhong HQ, Guan GY, et al
    Association of previous schistosome infection with fatty liver and coronary heart disease: a cross-sectional study in China.
    Parasite Immunol. 2021 Jan 17:e12822. doi: 10.1111/pim.12822.
    PubMed     Abstract available


    December 2020
  4. MOHAMMADI AM, Duthie MS, Reed SG, Javadi A, et al
    Evolution of antigen-specific immune responses in cutaneous leishmaniasis patients.
    Parasite Immunol. 2020 Dec 22:e12814. doi: 10.1111/pim.12814.
    PubMed     Abstract available


    November 2020
  5. AGHAEI M, Khanahmad H, Aghaei S, Hosseini SM, et al
    Evaluation of transgenic Leishmania infantum expressing mLLO-BAX-SMAC in the apoptosis of the infected macrophages in vitro and in vivo.
    Parasite Immunol. 2020;42:e12726.
    PubMed     Abstract available


    October 2020
  6. HUSSAIN A, Ghosh S, Roy K, Nath S, et al
    A mushroom derived 'carbohydrate-fraction' reinstates host-immunity and protects from Leishmania donovani infection.
    Parasite Immunol. 2020 Oct 31:e12806. doi: 10.1111/pim.12806.
    PubMed     Abstract available


  7. DUTRA BM, de Castro Rodrigues NL, Fonseca FRM, de Moura TR, et al
    CXCL10 immunomodulatory effect against infection caused by an antimony refractory isolate of Leishmania braziliensis in mice.
    Parasite Immunol. 2020 Oct 31:e12805. doi: 10.1111/pim.12805.
    PubMed     Abstract available


  8. GONZALEZ K, Calzada JE, Tomokane TY, Sandoval Pacheco CM, et al
    In situ study of cellular immune response in human cutaneous lesions caused by Leishmania (Viannia) panamensis in Panama.
    Parasite Immunol. 2020 Oct 17. doi: 10.1111/pim.12801.
    PubMed     Abstract available


    September 2020
  9. LIMA SS, Braz DC, Silva VC, de Jesus Cardoso Farias Pereira T, et al
    Biomarkers of the early response to treatment of visceral leishmaniasis: a prospective cohort study.
    Parasite Immunol. 2020 Sep 27:e12797. doi: 10.1111/pim.12797.
    PubMed     Abstract available


  10. NATEGHI ROSTAMI M
    CRISPR/Cas9 gene drive technology to control transmission of vector-borne parasitic infections.
    Parasite Immunol. 2020;42:e12762.
    PubMed     Abstract available


  11. NAVA-CASTRO KE, Togno-Peirce C, Palacios-Arreola MI, Del Rio-Araiza VH, et al
    Bisphenol A induces protection through modulation of the immune response against the helminth parasite Taenia crassiceps.
    Parasite Immunol. 2020;42:e12733.
    PubMed     Abstract available


    August 2020
  12. MORAVEJ A, Choopanizadeh M, Pourabbas B, Pouladfar G, et al
    Treatment effects on IL-9+CD4+T cells and the cytokines influencing IL-9 production in pediatric visceral leishmaniasis.
    Parasite Immunol. 2020 Aug 18:e12787. doi: 10.1111/pim.12787.
    PubMed     Abstract available


  13. GUAN F, Zhang C, Jiang C, Lupemba Jacques M, et al
    ApoE deficiency promotes hepatic pathology by aggravating Th17/Treg imbalance in murine schistosomiasis japonica.
    Parasite Immunol. 2020 Aug 12:e12785. doi: 10.1111/pim.12785.
    PubMed     Abstract available


  14. PEREIRA IAG, Mendonca DVC, Tavares GSV, Lage DP, et al
    Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
    Parasite Immunol. 2020 Aug 9:e12784. doi: 10.1111/pim.12784.
    PubMed     Abstract available


  15. SILVA LP, Paciello MO, Aviz Teixeira WP, Rivas AV, et al
    Immunogenicity of HLA-DR1 and HLA-A2 peptides derived from Leishmania major Gp63 in golden hamsters.
    Parasite Immunol. 2020 Aug 1:e12780. doi: 10.1111/pim.12780.
    PubMed     Abstract available


    July 2020
  16. MOULIK S, Karmakar J, Joshi S, Dube A, et al
    Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis.
    Parasite Immunol. 2020 Jul 31:e12783. doi: 10.1111/pim.12783.
    PubMed     Abstract available


  17. LLANWARNE F, Helmby H
    Granuloma formation and tissue pathology in Schistosoma japonicum versus Schistosoma mansoni infections.
    Parasite Immunol. 2020 Jul 21:e12778. doi: 10.1111/pim.12778.
    PubMed     Abstract available


  18. KIRIK FE, Ulger M, Tezcan Ulger S, Aslan G, et al
    Association of cytokine gene polymorphisms with susceptibility to cutaneous leishmaniasis in a Turkish population.
    Parasite Immunol. 2020 Jul 13:e12775. doi: 10.1111/pim.12775.
    PubMed     Abstract available


    June 2020
  19. FLORES GA, Sandoval Pacheco CM, Sosa Ochoa WH, Gomes C, et al
    Th17 lymphocytes in atypical cutaneous leishmaniasis caused by Leishmania (L.) infantum chagasi in Central America.
    Parasite Immunol. 2020 Jun 30:e12772. doi: 10.1111/pim.12772.
    PubMed     Abstract available


  20. SAINI S, Rai AK
    Hamster, a close model for visceral leishmaniasis: opportunities and challenges.
    Parasite Immunol. 2020 Jun 28:e12768. doi: 10.1111/pim.12768.
    PubMed     Abstract available


  21. KARIMI KAKH M, Golchin M, Kazemi Arababadi M, Daneshvar H, et al
    Application of the Leishmania infantum 21 kDa recombinant protein for the development of an immunochromatographic test.
    Parasite Immunol. 2020 Jun 26:e12770. doi: 10.1111/pim.12770.
    PubMed     Abstract available


  22. VILLANUEVA-LIZAMA LE, Cruz-Chan JV, Versteeg L, Teh-Poot CF, et al
    TLR4 agonist protects against Trypanosoma cruzi acute lethal infection by decreasing cardiac parasite burdens.
    Parasite Immunol. 2020 Jun 26:e12769. doi: 10.1111/pim.12769.
    PubMed     Abstract available


    May 2020
  23. PARODI C, Barrio A, Garcia Bustos MF, Gonzalez Prieto AG, et al
    B cell profile, B-cell activating factor concentration and IgG levels in human cutaneous and mucosal leishmaniasis.
    Parasite Immunol. 2020 May 27:e12759. doi: 10.1111/pim.12759.
    PubMed     Abstract available


  24. PANDEY SC, Kumar A, Samant M
    Genetically modified live attenuated vaccine: a potential strategy to combat visceral leishmaniasis.
    Parasite Immunol. 2020 May 17:e12732. doi: 10.1111/pim.12732.
    PubMed     Abstract available


  25. MISRA P, Tandon R, Basak T, Sengupta S, et al
    Purified Splenic amastigotes of Leishmania donovani-Immunoproteomic approach for exploring Th1 stimulatory polyproteins.
    Parasite Immunol. 2020 May 16:e12729. doi: 10.1111/pim.12729.
    PubMed     Abstract available


  26. KUMAR A, Pandey SC, Samant M
    A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis.
    Parasite Immunol. 2020 May 7:e12727. doi: 10.1111/pim.12727.
    PubMed     Abstract available


    April 2020
  27. HASBY SAAD MA, El-Anwar N
    Bevacizumab as a potential anti-angiogenic therapy in schistosomiasis: A double edged, but adjustable weapon.
    Parasite Immunol. 2020 Apr 27:e12724. doi: 10.1111/pim.12724.
    PubMed     Abstract available


  28. PESSENDA G, Santana da Silva J
    Arginase and its mechanisms in Leishmania persistence.
    Parasite Immunol. 2020 Apr 15:e12722. doi: 10.1111/pim.12722.
    PubMed     Abstract available


  29. ABU ALSHAMAT E, Kweider M, Abbady AQ
    Camel Nanobodies: Promising Molecular Tools Against Leishmaniasis.
    Parasite Immunol. 2020 Apr 6:e12718. doi: 10.1111/pim.12718.
    PubMed     Abstract available


  30. MAJUMDER N, Ganguly S, Ghosh AK, Kundu S, et al
    Chlorogenic acid acts upon Leishmania donovani arresting cell cycle and modulating cytokines and nitric oxide in vitro.
    Parasite Immunol. 2020 Apr 5:e12719. doi: 10.1111/pim.12719.
    PubMed     Abstract available


    March 2020
  31. VENTURIN GL, Bragato JP, Melo LM, Rebech GT, et al
    Eegulatory effect of PGE2 on microbicidal activity and inflammatory cytokines in canine leishmaniasis.
    Parasite Immunol. 2020 Mar 16. doi: 10.1111/pim.12713.
    PubMed     Abstract available


  32. MAJER M, Machacek T, Sukenikova L, Hrdy J, et al
    The peripheral immune response of mice infected with a neuropathogenic schistosome.
    Parasite Immunol. 2020 Mar 7:e12710. doi: 10.1111/pim.12710.
    PubMed     Abstract available


    February 2020
  33. TOKPLONOU L, Nouatin O, Sonon P, M'po G, et al
    Schistosoma haematobium infection modulates Plasmodium falciparum parasite density and antimalarial antibody responses.
    Parasite Immunol. 2020 Feb 5:e12702. doi: 10.1111/pim.12702.
    PubMed     Abstract available


  34. ISAAC-MARQUEZ AP, Lezama-Davila CM
    Cytokine regulation of female-macrophage resistance to Leishmania mexicana parasites. Role of IL-12p70.
    Parasite Immunol. 2020;42:e12685.
    PubMed     Abstract available


    January 2020
  35. BARBOSA JUNIOR WL, Justo AM, Aguiar Dos Santos AM, de Lorena VMB, et al
    Higher levels of TNF and IL-4 cytokines and low miR-182 expression in visceral leishmaniasis-HIV co-infected patients.
    Parasite Immunol. 2020 Jan 28:e12701. doi: 10.1111/pim.12701.
    PubMed     Abstract available


    December 2019
  36. LEOW CY, Willis C, Chuah C, Leow CH, et al
    Immunogenicity, antibody responses and vaccine efficacy of recombinant annexin B30 against Schistosoma mansoni.
    Parasite Immunol. 2019 Dec 27:e12693. doi: 10.1111/pim.12693.
    PubMed     Abstract available


  37. NAHIDI S, Gholami E, Taslimi Y, Habibzadeh S, et al
    The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica.
    Parasite Immunol. 2019 Dec 7:e12691. doi: 10.1111/pim.12691.
    PubMed     Abstract available


  38. ZUTSHI S, Kumar S, Sarode A, Roy S, et al
    Leishmania major Adenylate kinase immunization offers partial protection to a susceptible host.
    Parasite Immunol. 2019 Dec 4:e12688. doi: 10.1111/pim.12688.
    PubMed     Abstract available


    November 2019
  39. KUMAR S, Zutshi S, Patidar A, Bodhale N, et al
    LmjMAPK10 offers protection against Leishmania donovani infection.
    Parasite Immunol. 2019 Nov 26:e12687. doi: 10.1111/pim.12687.
    PubMed     Abstract available


  40. OLIVEIRA DOS SANTOS MACIEL M, Soares MF, Costa SF, Bragato JP, et al
    Plasmonic rK28 ELISA improves the diagnosis of canine Leishmania infection.
    Parasite Immunol. 2019 Nov 15:e12684. doi: 10.1111/pim.12684.
    PubMed     Abstract available


    October 2019
  41. KUMAR JHA M, Rao SJ, Sarode AY, Saha B, et al
    A Leishmania donovani Dominant Negative Mutant for eIF2alpha kinase LdeK1 elicits host-protective immune response.
    Parasite Immunol. 2019 Oct 14. doi: 10.1111/pim.12678.
    PubMed     Abstract available


  42. AZIZI M, Yousefi R, Yeganeh F, Mami S, et al
    Co-administration of Chitin Micro-particle and Leishmania Antigen Proposed a New Immune Adjuvant against Experimental Leishmaniasis.
    Parasite Immunol. 2019 Oct 8:e12676. doi: 10.1111/pim.12676.
    PubMed     Abstract available


    September 2019
  43. DA PAIXAO DE SOUZA R, Araujo MI, Lopes DM, Verde Santana de Almeida TV, et al
    Characterization of memory T cells in individuals resistant to Schistosoma mansoni infection.
    Parasite Immunol. 2019 Sep 18:e12671. doi: 10.1111/pim.12671.
    PubMed     Abstract available


  44. SINGH B, Bhushan Chauhan S, Kumar R, Sankar Singh S, et al
    A molecular signature for CD8(+) T cells from visceral leishmaniasis patients.
    Parasite Immunol. 2019 Sep 8:e12669. doi: 10.1111/pim.12669.
    PubMed     Abstract available


    July 2019
  45. SOUZA KD, Fernandes EPA, Dos Santos AGA, de Lima LL, et al
    Infection by Leishmania (Leishmania) infantum chagasi causes intestinal changes B-1 cells dependent.
    Parasite Immunol. 2019 Jul 3:e12661. doi: 10.1111/pim.12661.
    PubMed     Abstract available


  46. PATEL H, Althubaiti N, Parmar R, Yadav N, et al
    Parasite load stemming from immunization route determines the duration of liver-stage immunity.
    Parasite Immunol. 2019;41:e12622.
    PubMed     Abstract available


    June 2019
  47. VIANA AG, Magalhaes LMD, Giunchetti RC, Dutra WO, et al
    Leishmania infantum induces expression of the negative regulatory checkpoint, CTLA-4, by human naive CD8+ T cells.
    Parasite Immunol. 2019 Jun 7:e12659. doi: 10.1111/pim.12659.
    PubMed     Abstract available


  48. CHICO ME, Vaca MG, Rodriguez A, Cooper PJ, et al
    Soil-transmitted helminth parasites and allergy: Observations from Ecuador.
    Parasite Immunol. 2019;41:e12590.
    PubMed     Abstract available


  49. MPAIRWE H, Amoah AS
    Parasites and allergy: Observations from Africa.
    Parasite Immunol. 2019;41:e12589.
    PubMed     Abstract available


  50. DE ANDRADE CM, Carneiro VL, Cerqueira JV, Fonseca HF, et al
    Parasites and allergy: Observations from Brazil.
    Parasite Immunol. 2019;41:e12588.
    PubMed     Abstract available


  51. MCSORLEY HJ, Chaye MAM, Smits HH
    Worms: Pernicious parasites or allies against allergies?
    Parasite Immunol. 2019;41:e12574.
    PubMed     Abstract available


    May 2019
  52. TANG LC, Pan Q, Dai WQ, Hu LD, et al
    Administration of anti-CTLA-4 monoclonal antibody augments protective immunity induced by Schistosoma japonicum glutathione-S-transferase.
    Parasite Immunol. 2019 May 24:e12657. doi: 10.1111/pim.12657.
    PubMed     Abstract available


    March 2019
  53. QUIXABEIRA VBL, de Araujo Pereira LI, Veras PRV, da Costa ACV, et al
    Alterations in monocyte subsets and cytokine production after TLR activation in American Cutaneous Leishmaniasis.
    Parasite Immunol. 2019 Mar 14:e12623. doi: 10.1111/pim.12623.
    PubMed     Abstract available


    February 2019
  54. DE SOUZA CARDOSO TM, Bezerra C, Medina LS, Ramasawmy R, et al
    Leishmania braziliensis Isolated from Disseminated leishmaniasis Patients Down Modulate Neutrophil Function.
    Parasite Immunol. 2019 Feb 27:e12620. doi: 10.1111/pim.12620.
    PubMed     Abstract available


  55. CLASSON C, Feng X, Eidsmo L, Nylen S, et al
    Intestinal Nematode Infection Exacerbates Experimental Visceral Leishmaniasis.
    Parasite Immunol. 2019 Feb 11:e12618. doi: 10.1111/pim.12618.
    PubMed     Abstract available


  56. PEREIRA MA, Alexandre-Pires G, Camara M, Santos M, et al
    Canine neutrophils cooperate with macrophages in the early stages of Leishmania infantum in vitro infection.
    Parasite Immunol. 2019 Feb 8:e12617. doi: 10.1111/pim.12617.
    PubMed     Abstract available


    November 2018
  57. DIUPOTEX M, Martinez-Salazar MB, Escalona-Montano AR, Zamora-Chimal J, et al
    The mKate fluorescent protein expressed by Leishmania mexicana modifies the parasite immunopathogenicity in BALB/c mice.
    Parasite Immunol. 2018 Nov 30:e12608. doi: 10.1111/pim.12608.
    PubMed     Abstract available


  58. HEIDARI-KHARAJI M, Fallah-Omrani V, Badirzadeh A, Mohammadi-Ghalehbin B, et al
    Sambucus ebulus extract stimulates cellular responses in cutaneous leishmaniasis.
    Parasite Immunol. 2018 Nov 25:e12605. doi: 10.1111/pim.12605.
    PubMed     Abstract available


  59. FUKUSHIGE M, Mutapi F, Woolhouse MEJ
    Population level changes in schistosome specific antibody levels following chemotherapy.
    Parasite Immunol. 2018 Nov 22:e12604. doi: 10.1111/pim.12604.
    PubMed     Abstract available


  60. LE L, Mbanefo E, Khludenev G, Lamanna O, et al
    Schistosoma haematobium Cercarial Infection Alters Subsequent Systemic Immune Responses to Eggs But Has Minimal Impact on Immune Responses to Egg Injection of the Bladder.
    Parasite Immunol. 2018 Nov 11:e12602. doi: 10.1111/pim.12602.
    PubMed     Abstract available


  61. SINGH B, Singh SS, Sundar S
    Hepcidin mediated iron homeostasis as immune regulator in visceral leishmaniasis patients.
    Parasite Immunol. 2018 Nov 6:e12601. doi: 10.1111/pim.12601.
    PubMed     Abstract available


    September 2018
  62. EGESA M, Lubyayi L, Jones FM, van Diepen A, et al
    Antibody Responses to Schistosoma mansoni Schistosomula Antigens.
    Parasite Immunol. 2018 Sep 21:e12591. doi: 10.1111/pim.12591.
    PubMed     Abstract available


  63. EGESA M, Lubyayi L, Tukahebwa EM, Bagaya BS, et al
    S. mansoni Schistosomula Antigens Induce Th1/Proinflammatory Cytokine Responses.
    Parasite Immunol. 2018 Sep 21:e12592. doi: 10.1111/pim.12592.
    PubMed     Abstract available


  64. KUMAR A, Das S, Mandal A, Verma S, et al
    Leishmania infection activates host mTOR for its survival by M2 macrophage polarization.
    Parasite Immunol. 2018 Sep 6:e12586. doi: 10.1111/pim.12586.
    PubMed     Abstract available


    August 2018
  65. ABEIJON C, Dilo J, Tremblay JM, Viana AG, et al
    Use of VHH antibodies for development of antigen detection test for visceral leishmaniasis.
    Parasite Immunol. 2018 Aug 18:e12584. doi: 10.1111/pim.12584.
    PubMed     Abstract available


  66. OBIEGLO K, Schuijs MJ, Ozir-Fazalalikhan A, Otto F, et al
    Isolated Schistosoma mansoni eggs prevent allergic airway inflammation.
    Parasite Immunol. 2018 Aug 14:e12579. doi: 10.1111/pim.12579.
    PubMed     Abstract available


  67. WANG X, Fu Q, Song R, Duan B, et al
    Antinuclear antibodies and interleukin responses in patients with Schistosoma japonicum infection.
    Parasite Immunol. 2018 Aug 3:e12577. doi: 10.1111/pim.12577.
    PubMed     Abstract available


    June 2018
  68. COSTA SF, Trivellato GF, Rebech GT, Oliveira Dos Santos Maciel M, et al
    Eosinophilic inflammation in lymph nodes of dogs with visceral leishmaniasis.
    Parasite Immunol. 2018 Jun 19:e12567. doi: 10.1111/pim.12567.
    PubMed     Abstract available


  69. RODRIGUES-ALVES ML, Melo-Junior OAO, Coelho-Dos-Reis JG, Pascoal-Xavier MA, et al
    Fcgamma-RI, Fcgamma-RII and IL-10 as predictive biomarkers for post-therapeutic cicatrization time in monocytes from Cutaneous Leishmaniasis patients.
    Parasite Immunol. 2018 Jun 16:e12565. doi: 10.1111/pim.12565.
    PubMed     Abstract available


  70. GALINDO-SEVILLA N, Mancilla-Ramirez J
    T cell tolerance as a potential effect of congenital leishmaniasis on offspring immunity.
    Parasite Immunol. 2018 Jun 11:e12540. doi: 10.1111/pim.12540.
    PubMed     Abstract available


    May 2018
  71. ROY S, Mukhopadhyay D, Mukherjee S, Moulik S, et al
    An IL-10 dominant polarization of monocytes is a feature of Indian Visceral Leishmaniasis.
    Parasite Immunol. 2018 May 10:e12535. doi: 10.1111/pim.12535.
    PubMed     Abstract available


    April 2018
  72. ZAVALA GA, Garcia OP, Camacho M, Ronquillo D, et al
    Intestinal parasites: Associations with intestinal and systemic inflammation.
    Parasite Immunol. 2018;40:e12518.
    PubMed     Abstract available


    March 2018
  73. NDOMBI EM, Abudho B, Kittur N, Carter JM, et al
    Anti-schistosome responses after four annual treatments.
    Parasite Immunol. 2018 Mar 31:e12530. doi: 10.1111/pim.12530.
    PubMed     Abstract available


  74. XU L, Xue B, Zhou L, Qiu Z, et al
    NP30 stimulates Th17 differentiation through DC in Schistosomiasis Japonicum.
    Parasite Immunol. 2018 Mar 25:e12528. doi: 10.1111/pim.12528.
    PubMed     Abstract available


  75. POLANDO RE, Jones BC, Ricardo C, Whitcomb J, et al
    MR and TLR2 influence phagosome maturation during Leishmania infection.
    Parasite Immunol. 2018 Mar 6. doi: 10.1111/pim.12521.
    PubMed     Abstract available


    February 2018
  76. KEIRANDISH F, Mosaffa N, Tarahi MJ, Fallahi S, et al
    Olive (Olea europaea) leaf extract alters the cytokine profile of Leishmania major-infected macrophages: New insight into the underlying mechanism.
    Parasite Immunol. 2018 Feb 16. doi: 10.1111/pim.12520.
    PubMed     Abstract available


    January 2018
  77. COSTA SDS, Fornazim MC, Nowill AE, Giorgio S, et al
    Leishmania amazonensis induces modulation of costimulatory and surface markers molecules in human macrophages.
    Parasite Immunol. 2018 Jan 30. doi: 10.1111/pim.12519.
    PubMed     Abstract available


  78. MOURGLIA-ETTLIN G, Miles S, Hernandez A, Dematteis S, et al
    Ageing impairs parasite-specific antibody responses in cystic echinococcosis.
    Parasite Immunol. 2018;40.
    PubMed     Abstract available


    December 2017
  79. DINGA JN, Gamua DS, Ghogomu SM, Titanji VPK, et al
    Preclinical efficacy and immunogenicity assessment to show that a chimeric Plasmodium falciparum UB05-09 antigen could be a Malaria Vaccine Candidate.
    Parasite Immunol. 2017 Dec 28. doi: 10.1111/pim.12514.
    PubMed     Abstract available


  80. SANCHEZ-GARCIA L, Wilkins-Rodriguez A, Salaiza-Suazo N, Morales-Montor J, et al
    Dihydrotestosterone enhances growth and infectivity of Leishmania Mexicana.
    Parasite Immunol. 2017 Dec 22. doi: 10.1111/pim.12512.
    PubMed     Abstract available


  81. NABAVI NS, Pezeshkpoor F, Valizadeh N, Ahmadi Ghezeldasht S, et al
    Increased Th17 functions are accompanied by Tregs activities in lupoid leishmaniasis.
    Parasite Immunol. 2017 Dec 4. doi: 10.1111/pim.12507.
    PubMed     Abstract available


    November 2017
  82. NKURUNUNGI G, Kabagenyi J, Nampijja M, Sanya RE, et al
    Schistosoma mansoni-specific immune responses and allergy in Uganda.
    Parasite Immunol. 2017 Nov 24. doi: 10.1111/pim.12506.
    PubMed     Abstract available


  83. PEREIRA-FONSECA DCM, Oliveira-Rovai FM, Rodas LAC, Beloti CAC, et al
    Dog skin parasite load, TLR-2, IL-10 and TNF-alpha expression and infectiousness.
    Parasite Immunol. 2017;39.
    PubMed     Abstract available


    September 2017
  84. NASERI H, Eskandari F, Jaafari MR, Khamesipour A, et al
    Pegylation of Cationic Liposomes Encapsulating Soluble Leishmania Antigens (SLA) Reduces the Adjuvant Efficacy of Liposomes in Murine Model.
    Parasite Immunol. 2017 Sep 16. doi: 10.1111/pim.12492.
    PubMed     Abstract available


  85. SANCHEZ MV, Elicabe RJ, Di Genaro MS, Germano MJ, et al
    Total Leishmania antigens with Poly(I:C) induce Th1 protective response.
    Parasite Immunol. 2017 Sep 13. doi: 10.1111/pim.12491.
    PubMed     Abstract available


    August 2017
  86. MARCONATO DG, do Nascimento Gusmao MA, Melo J, de Andrade Castro JM, et al
    Anti-schistosome antibodies change NTPDase 1 activity from macrophages.
    Parasite Immunol. 2017 Aug 30. doi: 10.1111/pim.12487.
    PubMed     Abstract available


  87. MONTAKHAB-YEGANEH H, Abdossamadi Z, Zahedifard F, Taslimi Y, et al
    Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against L. major-infected BALB/c mice.
    Parasite Immunol. 2017 Aug 18. doi: 10.1111/pim.12461.
    PubMed     Abstract available


    July 2017
  88. BADIRZADEH A, Taheri T, Abedi-Astaneh F, Taslimi Y, et al
    Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis.
    Parasite Immunol. 2017 Jul 21. doi: 10.1111/pim.12454.
    PubMed     Abstract available


  89. BUJARBARUAH D, Kalita MP, Baruah V, Basumatary TK, et al
    RANTES levels as a determinant of falciparum malaria severity or recovery.
    Parasite Immunol. 2017 Jul 7. doi: 10.1111/pim.12452.
    PubMed     Abstract available


    June 2017
  90. DIKHIT MR, Amit A, Singh AK, Kumar A, et al
    Vaccine potential of HLA A2 epitopes from Leishmania Cysteine Protease Type III (CPC).
    Parasite Immunol. 2017 Jun 30. doi: 10.1111/pim.12451.
    PubMed     Abstract available


  91. OLMOS-ORTIZ LM, Barajas-Mendiola MA, Barrios-Rodiles M, Castellano LE, et al
    Trichomonas vaginalis exosome-like vesicles modify the cytokine profile and reduce inflammation in parasite-infected mice.
    Parasite Immunol. 2017;39.
    PubMed     Abstract available


    May 2017
  92. NYHALAH DJ, Dobgima GS, Titanji VP
    Enhanced acquired antibodies to a chimeric Plasmodium falciparum antigen; UB05-09 is associated with protective immunity against malaria.
    Parasite Immunol. 2017 May 24. doi: 10.1111/pim.12445.
    PubMed     Abstract available


  93. RODRIGUEZ NE, Lockard RD, Turcotte EA, Araujo-Santos T, et al
    Lipid bodies accumulation in Leishmania infantum-infected C57BL/6 macrophages.
    Parasite Immunol. 2017 May 18. doi: 10.1111/pim.12443.
    PubMed     Abstract available


  94. SHEA-DONOHUE T, Qin B, Smith A
    Parasites, nutrition, immune responses and biology of metabolic tissues.
    Parasite Immunol. 2017;39.
    PubMed     Abstract available


  95. BHATTACHARJEE S, Kalbfuss N, Prazeres da Costa C
    Parasites, microbiota and metabolic disease.
    Parasite Immunol. 2017;39.
    PubMed     Abstract available


    April 2017
  96. MOREIRA RB, Pirmez C, De Oliveira-Neto MP, De Souza Aguiar L, et al
    AIM2 inflammasome is associated to disease severity in tegumentary leishmaniasis caused by Leishmania (V.) braziliensis.
    Parasite Immunol. 2017 Apr 11. doi: 10.1111/pim.12435.
    PubMed     Abstract available


  97. BOSTROM S, Schmiegelow C, Abu Abed U, Minja DT, et al
    Neutrophil alterations in pregnancy associated malaria and induction of neutrophil chemotaxis by Plasmodium falciparum.
    Parasite Immunol. 2017 Apr 5. doi: 10.1111/pim.12433.
    PubMed     Abstract available


    March 2017
  98. SALIH MA, Fakiola M, Lyons PA, Younis BM, et al
    Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate.
    Parasite Immunol. 2017 Mar 31. doi: 10.1111/pim.12431.
    PubMed     Abstract available


    January 2017
  99. MUNOZ-CARRILLO JL, Munoz-Escobedo JJ, Maldonado-Tapia CH, Chavez-Ruvalcaba F, et al
    Resiniferatoxin lowers TNF-alpha, NO and PGE2 in the intestinal phase and the parasite burden in the muscular phase of Trichinella spiralis infection.
    Parasite Immunol. 2017;39.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: